Your browser doesn't support javascript.
loading
Efficacy and safety of sacubitril/valsartan on heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
Yu, Wanqian; Zhang, Hongzhou; Shen, Wen; Luo, Fan; Yang, Shuai; Gan, Lujin; Zhao, Yuanbin; Yang, Pingping; Wu, Qinghua.
Affiliation
  • Yu W; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Zhang H; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Shen W; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Luo F; Medical Center of the Graduate School, Nanchang University, Nanchang, China.
  • Yang S; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Gan L; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Zhao Y; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Yang P; Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Wu Q; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Front Cardiovasc Med ; 9: 897423, 2022.
Article in En | MEDLINE | ID: mdl-36158828
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Clinical_trials / Systematic_reviews Language: En Journal: Front Cardiovasc Med Year: 2022 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Type of study: Clinical_trials / Systematic_reviews Language: En Journal: Front Cardiovasc Med Year: 2022 Type: Article Affiliation country: China